Clinical Trial: A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07293364) titled 'A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema' on Dec. 08.

Brief Summary: Hereditary angioedema (HAE) is a rare condition. It causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. This swelling happens because of a temporary leak in blood vessels but does not cause itching or hives. HAE is classified based on the amount of a protein in the blood called C1-inhibitor (C1INH): HAE with normal C1INH levels and function (HAE-nC1INH) and HAE with deficiency in C1INH levels (HAE-C1INH-Type1) or dysfunction (HAE-C1INH-Type2). This study will focus on the ...